Key Takeaways
- Traditional practice brokers usually match sellers with individual dentist buyers using collections-based pricing. Dental-specific M&A advisors typically run structured processes across both private and institutional buyer pools.
- Practices under $1.5M revenue can be well served by brokers with strong private-buyer networks. Practices above $3M often benefit from M&A advisors pursuing DSO buyers that pay higher EBITDA-based prices.
- The $1.5–3M middle market can attract both buyer types, so a side-by-side valuation can help show which path may produce a stronger outcome.
- Competitive tension created through structured bid processes can generate around 10 offers and can support roughly a 30% valuation lift compared with single-buyer negotiations.
- McLerran & Associates provides guidance across both transition paths. Request a free, confidential discovery call to review your options.
Match Your Practice Size to the Right Buyer Pool
Practice value often depends first on who can realistically buy your practice at its current revenue level. Different buyer groups tend to pay in different ways, and choosing the wrong lane can quietly reduce your outcome.
A practical starting framework looks like this:
- Under $1–1.5M in annual revenue. The most natural buyer is usually another dentist. Individual doctor-buyers using SBA financing generally pay 60–80% of trailing 12-month collections. That price is constrained by what the practice can support in post-close debt payments rather than by an EBITDA multiple. EBITDA, or earnings before interest, taxes, depreciation, and amortization, is the profitability figure institutional buyers use to set price. A traditional broker with a strong private-buyer network can serve this segment well.
- Above $3M in annual revenue. At this scale, the practice often generates enough adjusted EBITDA to attract serious institutional interest. Multi-location dental groups with $1M+ adjusted EBITDA traded at 8x to 11x adjusted EBITDA in 2026, a range that individual buyers financed through conventional lending typically cannot reach. A dental-specific M&A advisor running a competitive DSO (Dental Service Organization) bid process is usually the appropriate professional here.
- The $1.5–3M middle market. Owners in this range can often attract both buyer types. The better path can depend on practice-specific variables such as EBITDA margin, associate structure, specialty, and the owner’s personal goals. Modeling both paths side by side can clarify which route may be more favorable.
Not sure where your practice falls? Get a clear picture of your options in a free, confidential discovery call with McLerran & Associates.
Use Competition to Strengthen Your Position
The main structural difference between a broker and a sell-side advisor is whether the professional creates real competitive tension among multiple buyers, or simply introduces one buyer and negotiates from there. Once you understand which buyer pool your practice can access, the next step is deciding how to draw out the strongest offers from that pool.
The table below compares traditional brokers and dental-specific sell-side M&A advisors across key factors for a first-time seller.
| Attribute | Traditional Practice Broker | Dental-Specific Sell-Side M&A Advisor |
|---|---|---|
| Valuation methodology | Collections-based pricing (typically 60–85% of trailing 12-month collections) for doctor-to-doctor deals | Adjusted EBITDA multiple with full add-back normalization and diligence-grade quality-of-earnings work |
| Buyer pool size | Local or regional individual dentists with limited DSO relationships | Vetted national pool of DSOs, private equity platforms, and family offices |
| Competitive tension | Minimal, so unrepresented sellers can lose significant practice value due to limited buyer exposure | Structured auction process generating multiple offers, with competition that can push price and terms upward |
| Close rates | Approximately 50% of healthcare practice sales attempted without professional representation fail to close, with an industry broker norm closer to 35–40% | Legitimate dental M&A advisors often report close rates of 65–85% for deals engaged in the past 24 months |
| Fee model | Success fee of 8–12% of final sale price, paid at closing, and some firms charge upfront listing fees of $1,000–$5,000 | Monthly retainer plus success fee, with retainers typically ranging from $10,000 to $50,000 per month for 3–6 months that cover EBITDA normalization and deal preparation |
| Re-trading risk | High, because weak valuation work is vulnerable when buyers scrutinize financials in due diligence | Re-trading can still occur in exclusive due diligence when issues surface, but a strong advisor works to defend value |
McLerran & Associates fits the dental-specific sell-side advisor model and focuses on creating this type of competitive environment. The firm’s DSO bid processes typically run 45–60 days and generate around 10 offers from vetted buyers, which can support the ~30% valuation lift discussed earlier.
Choose a Path in the $1.5–3M “Venn Diagram” Range
Owners in the $1.5–3M revenue range occupy a genuinely unique position in the dental transition market. As noted earlier, practices in this band can often attract both serious institutional interest and strong private-buyer demand. Neither path is automatically superior, because the better choice can depend on the owner’s specific numbers, goals, and timeline.
This segment is where a single-lane professional, such as a broker who only handles doctor-to-doctor deals or an advisor who only pursues DSO affiliations, can create a structural disadvantage for the seller. Without a genuine side-by-side comparison, the owner is choosing a path based on partial information.
McLerran & Associates works both transition paths in roughly equal measure, with approximately a 50/50 split between private-buyer and DSO transactions. That experience allows the firm to produce a true comparison of what a practice may be worth to an individual dentist buyer versus what it could command in a competitive DSO process. The owner can then choose a direction with fuller information instead of a guess.
Request a side-by-side valuation from McLerran & Associates to see how both paths could look for your practice.
Build a Defensible Valuation Before You Go to Market
Valuation is often where the most financial damage in a dental practice sale occurs quietly. A quick, free estimate, often used as a lead-generation tool, can become the anchor that determines what the owner ultimately receives. When that number cannot withstand scrutiny, re-trading during exclusive due diligence can erode value after the letter of intent is signed.
McLerran & Associates addresses this risk with a CPA-led EBITDA analysis completed before the practice goes to market. This analysis identifies every legitimate add-back, including owner compensation above market rate, personal expenses run through the business, one-time costs, and above-market rent to owner-controlled entities, and documents each one with supporting evidence. That documentation helps turn EBITDA from a negotiable claim into a defensible figure, which can reduce buyer risk and support stronger negotiation on EBITDA multiple, deal structure, and terms.
From that foundation, the firm runs a structured, auction-style bid process that typically lasts 45–60 days and generates around 10 offers from a vetted pool of institutional buyers. The competitive tension that process creates is a key mechanism behind the ~30% valuation lift compared with going to market alone. Because McLerran’s quality-of-earnings work remains active through diligence, the agreed value is more likely to hold when buyers review the details.
The outcome data reflects this approach, as McLerran & Associates’ transaction rate significantly exceeds the broader industry norm and typical do-it-yourself close rates.
Watch for Red Flags When Hiring a Broker or Advisor
Certain patterns can signal that a broker or sell-side advisor may not serve a practice owner’s interests effectively.
- A “free” valuation with no CPA involvement and no explanation of add-backs, which often functions as a lead magnet rather than a defensible number.
- A professional who knows only one or two DSO buyers, which limits competitive tension before the process even starts.
- No clear explanation of how the firm defends valuation through due diligence if a buyer attempts to re-trade the deal.
- A firm that represents both buyers and sellers, because true sell-side representation usually requires undivided loyalty to the selling doctor.
- Promises of a specific multiple without first analyzing the practice’s financials, specialty, payor mix, and market, even though payor mix alone can drive one to two turns of intra-band variance in dental valuations.
- No track record of closed transactions in the practice’s revenue range or specialty.
- Pressure to sign quickly before the owner has reviewed a clear comparison of available paths.
Frequently Asked Questions
What is the difference between a dental practice broker and a sell-side M&A advisor?
A dental practice broker primarily matches a selling dentist with an individual buyer, usually another dentist, and earns a commission when the deal closes. The process is transactional: list the practice, find a buyer, and negotiate a price. A sell-side M&A advisor takes a more comprehensive approach by building a diligence-grade EBITDA analysis before going to market, running a structured competitive process among a vetted pool of buyers, and actively defending the agreed valuation through due diligence. This distinction can matter most for practices in the $1.5–3M revenue range, where both buyer types are viable and the difference in methodology can produce meaningfully different outcomes.
How do valuation methods differ between doctor-to-doctor sales and DSO transactions?
Doctor-to-doctor sales are typically priced as a percentage of trailing 12-month collections, which is constrained by what an individual buyer can finance through SBA or conventional lending. DSO and private equity buyers instead apply a multiple to adjusted EBITDA, which is the practice’s profitability after normalizing the owner’s compensation to a market-rate associate salary and adding back personal, one-time, and non-recurring expenses. Because EBITDA-based multiples are applied to a higher earnings base and at higher multiples than collections-based pricing, DSO transactions can produce substantially higher valuations for practices above roughly $1.5M in revenue. That outcome usually depends on building the EBITDA analysis correctly and defending it through diligence, since a weak or undocumented calculation is vulnerable to re-trading after the letter of intent is signed.
Why does competitive tension matter, and how does an advisor create it?
A practice owner who negotiates with a single buyer, whether an individual dentist or a DSO, has limited leverage. The buyer understands that no competing offer exists, and pricing often reflects that reality. A sell-side advisor creates competitive tension by running a structured, auction-style process among multiple pre-qualified buyers at the same time. When buyers know they are competing, they tend to bid more aggressively on both price and terms. McLerran & Associates’ DSO bid process typically runs 45–60 days and generates around 10 offers, which creates a competitive environment that individual sellers or single-buyer negotiations rarely match. This process also helps identify not just the highest bidder, but a buyer whose strategy, structure, and post-close support model align with what the selling doctor wants for the practice and for patients.
What should a practice owner in the $1.5–3M revenue range do first?
The most helpful first step is obtaining a clear comparison that quantifies the practice’s potential value in both the private-buyer and DSO markets. Without that comparison, choosing a path can feel like a guess. Owners in this range are often positioned to pursue either a doctor-to-doctor sale or a DSO affiliation, and the better answer can depend on variables such as EBITDA margin, associate structure, specialty, payor mix, and the owner’s personal goals around timing, clinical autonomy, and legacy. A firm that works both paths in roughly equal measure, and that builds its valuations to a diligence-grade standard, is usually well suited to produce that comparison. McLerran & Associates offers a free, confidential discovery call as a starting point for that discussion.
Choose Representation for a Once-in-a-Career Sale
A dental practice sale is often a once-in-a-lifetime transaction for the selling doctor and a weekly negotiation for many buyers. That information gap, rather than the complexity of the paperwork, can be one of the main reasons to consider a sell-side advisor.
For practices under $1–1.5M in revenue, a traditional broker with a strong private-buyer network can be the right fit. For practices above $3M, a dental-specific M&A advisor running a competitive institutional process is usually the appropriate professional. For the $1.5–3M middle market, many owners benefit from a firm that runs both paths in roughly equal measure and delivers a clear comparison before the owner commits to either direction.
McLerran & Associates has guided dentists through approximately 2,000 successful practice sales, evaluated more than 10,000 practices, and closed roughly $2 billion in transaction volume across nearly 35 years, with a transaction rate well above industry average and a reputation as a leading listing agent for premier dental practices. The firm is sell-side only, so its client is always the practice owner, never the buyer.
Schedule your free discovery call with McLerran & Associates to discuss your practice, your goals, and what both transition paths could realistically produce for you. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com/contact-us.
